Wird geladen...

Adoption of Injectable Naltrexone in U.S. Substance Use Disorder Treatment Programs

OBJECTIVE: Medication-assisted treatment for substance use disorders (SUDs) is not widely used in treatment programs. The aims of the current study were to document the prevalence of adoption and implementation of extended-release injectable naltrexone, the newest U.S. Food and Drug Administration–a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:J Stud Alcohol Drugs
Hauptverfasser: Aletraris, Lydia, Edmond, Mary Bond, Roman, Paul M
Format: Artigo
Sprache:Inglês
Veröffentlicht: Rutgers University 2015
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4263776/
https://ncbi.nlm.nih.gov/pubmed/25486403
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!